Rigel Reports Second Quarter 2022 Financial Results and Provides Business Update
Go back to Rigel Reports Second Quarter 2022 Financial Results and Provides Business Update| Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) | Delayed: 46.06 +1.58 (3.55%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $44.48 | 52 Week High | $4.38 | |||
| Open | $45.25 | 52 Week Low | $1.88 | |||
| Day High | $46.27 | P/E | N/A | |||
| Day Low | $45.14 | EPS | $-1.12 | |||
| Volume | 42,994 | |||||
